UC Launches Drug Discovery Consortium

Catherine Tralau-Stewart, UCSF

Note: The consortium brings together UC's five medical center campuses — Davis, Irvine, Los Angeles, San Diego and San Francisco — to share resources and expertise to help develop new drugs.

By Alec Rosenberg via UC Newsroom

To Get From Bench to Bedside, UCSF Scientists Get Help From Catalyst Program

By Dan Fost

To develop a new drug, or create a new diagnostic test or medical device, a scientist often needs a catalyst – something to spark the innovative idea that has the potential to change the way a disease is treated and improve patient outcomes.

Catalyst for Cures: UCSF Program Gives Hope to People with Rare Diseases

By Dan Fost

When a child is diagnosed with a rare and life-threatening disease, the parents often don’t know where to turn.

Mark Dant was told his toddler, Ryan, wouldn’t make it to his tenth birthday. Ryan had a rare genetic disorder, the doctors called it, Mucopolysaccharidosis (MPS I).

New Targeted Chemotherapy Technology Proves Effective in Mice

Compound Can be Administered at 50x Higher Doses and Effectively Shrinks Tumors with Few Side Effects in Mouse Tests

Virtually Biotechs

Why early stage academic deals are heating up

Lawmaker Wants to Fund More UC Innovation

Expanding Entrepreneurship at UCSF - QB3, Catalyst, ITA

UCSF Researchers Win Awards to Bring Treatments Out of Lab

Promising early stage research highlighted at Fall 2015 Catalyst Awards cycle event

MedImmune Announces Research Collaboration with UCSF Catalyst

Top scientists partner to research the progression and biology of RIA diseases

Eye Drops Could Clear Up Cataracts Using Newly Identified Chemical

Latest research published by UCSF-CTSI Catalyst Award winner